Prediction of Drug Penetration in Tuberculosis Lesions

Jansy P Sarathy1, Fabio Zuccotto2, Ho Hsinpin1

  • 1Public Health Research Institute Centre, New Jersey Medical School, Rutgers , 225 Warren Street, Newark, New Jersey 07103, United States.

ACS Infectious Diseases
|September 15, 2016
PubMed

Insights

Antibiotic penetration into tuberculosis lesions is uneven. Drug binding to lesion material (caseum) hinders diffusion, but molecular properties like shape and lipophilicity can predict better penetration for improved tuberculosis treatment.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Medicinal Chemistry

Background:

  • Antibiotic penetration into necrotic tuberculosis lesions (caseum) is variable and poorly understood.
  • Caseum is a critical site for Mycobacterium tuberculosis infection.
  • Factors influencing drug partitioning within caseum are unknown.

Purpose of the Study:

  • To investigate the factors governing antibiotic diffusion into necrotic tuberculosis lesions.
  • To develop predictive tools for optimizing drug properties for better caseum penetration.
  • To identify molecular characteristics that enhance or impede drug diffusion into caseum.

Main Methods:

  • Developed a caseum binding assay and a high-throughput assay using rapid equilibrium dialysis with a caseum surrogate.
  • Utilized MALDI mass spectrometry imaging to analyze drug distribution in caseum.
  • Profiled 279 compounds to identify physicochemical drivers of diffusion.
  • Applied principle component analysis and modeling to derive an in silico predictive signature.

Main Results:

  • Drug binding to caseum inversely correlated with passive diffusion.
  • High lipophilicity and poor solubility were major drivers of caseum binding.
  • Molecular shape descriptors (ring count, aromatic rings, sp(2) carbons, volume-to-surface ratio) influenced diffusion.
  • An in silico signature combining 69 molecular descriptors predicted caseum binding.
  • A simple rule of thumb related hydrophobicity and aromatic ring count to caseum binding.

Conclusions:

  • Drug binding to caseum macromolecules limits passive diffusion, impacting tuberculosis treatment efficacy.
  • Molecular properties, particularly lipophilicity and shape, are critical determinants of drug penetration into necrotic lesions.
  • Developed predictive tools and a rule of thumb to guide the design of new anti-tuberculosis drugs with improved caseum partitioning.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
609
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
728
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K